Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
Validation and cross-cultural adaptation of sexual dysfunction modified scale in multiple sclerosis for Brazilian population.
Caruifolin D from artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB signaling pathways.
Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
Relationship between urodynamic findings and sexual function in multiple sclerosis patients with lower urinary tract dysfunction.
Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
The therapeutic effect of Avonex, Rebif and Betaferon on quality of life in multiple sclerosis.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Guideline for the diagnosis and management of multiple sclerosis in children.
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis-related spasticity.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
The best clinical paper on multiple sclerosis in 2012: Commentary.
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.
Laquinimod in the treatment of relapsing remitting multiple sclerosis.
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Pertussis toxin promotes relapsing-remitting experimental autoimmune encephalomyelitis in Lewis rats.
Pages
« first
‹ previous
…
460
461
462
463
464
465
466
467
468
…
next ›
last »